News

Video

ASCRS 2025: Rotational stability and outcomes with 'monofocal plus' toric IOL with Gregory Moloney, FRANZCO, FRCSC

A study reports minimal rotation and improved near vision following implantation of the Eyhance toric lens.

Gregory Moloney, FRANZCO, FRCSC, presented a straightforward but impactful study evaluating a design modification in the Eyhance toric IOL at the 2025 American Society of Cataract and Refractive Surgery annual meeting, held April 25 to 28 in Los Angeles, California. "This study is simple. The message is really, really clear and quick," Moloney explained, setting the tone for his findings on rotational stability improvements.

The key change tested was the introduction of a frosted haptic, replacing the previous polished design. "We were looking to test whether or not a design modification in the Eyhance toric lens resulted in improved or better rotational stability," he said. Patients were assessed at day 1, week 1, and 3 months post-implantation.

The results were promising. In a cohort of 98 eyes from 65 patients, the mean IOL rotation was just 1.73 degrees. "The mean average IOL rotation was 1.73 degrees, which is really very acceptable," Moloney noted. Notably, 95% of patients experienced less than 5 degrees of rotation. "I think as surgeons that's reassuring for us that we can trust this platform," he added.

Beyond objective measurements, patient-reported outcomes were also encouraging. Using a near vision questionnaire, preoperative scores (typically around 20 to 23) dropped significantly to an average of 6 postoperatively, suggesting that "near vision tasks were perceived to be easier after implantation of this lens."

Summing up the study’s practical impact, Moloney stated, "All we wanted to know personally from our perspective was...can we trust this lens to be rotationally stable?" His conclusion was confident: "Surgeons can feel reassured that a rotation rate of under 5 degrees in almost every patient...is a stable platform."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.